Skip to main content

Table 1 Sociodemographic and clinical comorbidities among parkinsonian group (PG) and non-parkinsonian group (NPG)

From: Clinical and functional correlates of parkinsonism in a population-based sample of individuals aged 75 + : the Pietà study

Variable

PG

(N = 65)

NPG

(N = 542)

P-value

Sexa

n: 65

n: 542

0.608

    Female

40 (61.5)

351(64.8)

 

    Male

25 (38.5)

191(35.2)

 

Ageb

n: 65

n: 542

 < 0.001*

 

82.0 (78.0–87.0)

80.0 (77.0–83.0)

 

Schooling (years)b

n: 65

n: 542

0.154

 

2.0 (0.25–3.75)

3.0 (0.0–4.0)

 

Arterial hypertensiona

n: 65

n: 538

0.064

 

42 (64.6)

405 (75.3)

 

Diabetesa

n: 65

n: 533

0.868

 

13 (20.0)

102 (19.1)

 

Dyslipidemiaa

n: 65

n: 531

0.949

 

13 (20.0)

108 (20.3)

 

Osteoarthrosisa

n: 64

n: 529

0.118

 

14 (21.9)

166 (31.4)

 

Falls with fracturesa

n: 65

n: 540

0.008*

 

42 (64.6)†

255 (47.2)

 

History of strokea

n: 65

n: 542

 < 0.001*

 

11 (16.9)†

58 (10.7)

 

Coronary heart diseasec

n: 65

n: 539

0.511

 

4 (6.2)

22 (4.1)

 

Irregular cardiac rhythma

n: 62

n: 514

0.011*

 

15 (24.2)†

64 (12.5)

 

Carotid bruitsc

n: 60

n: 508

0.571

 

5 (8.3)

31 (6.1)

 

Smokinga

n: 61

n: 521

0.959

 

18 (29.5)

152 (29.2)

 

Alcohol usea

n: 57

n: 489

0.053

 

3 (5.3)

71 (14.5)

 

Ankle-brachial- indexa

n: 38

n: 355

0.125

    Normal

20 (52.6)

197 (55.5)

 

    Arterial calcification

7 (18.4)

30 (8.5)

 

    Peripheral occlusive disease

11 (28.4)

128 (36.1)

 

Diagnosis of depressiona

n: 65

n: 539

0.038*

 

21 (32.3)†

113 (21.0)

 

Physical activitiesa

n: 62

n: 520

0.007*

 

6 (9.7)

130 (25.0)†

 
  1. Data are presented either as absolute followed by relative frequency (%) or median (1st Quartile-3rd Quartile); n: number of subjects analyzed in the parkinsonian group or in the non-parkinsonian group; aPearson Chi-Square Test; bMann-Whitney Test; cFisher Exact Test; *p-values < 0.05; † adjusted residual value > 1.96